Literature DB >> 22783395

Expression of the TIMP2 gene is not regulated by promoter hypermethylation in the Caski cell line.

Gaurav Parashar1, Neena Capalash.   

Abstract

Promoter hypermethylation has been linked to loss of expression of tumor suppressor genes in various types of tumors. A strong reciprocal correlation between promoter hypermethylation and expression of the TIMP2 gene was observed in the Caski cell line. The TIMP2 promoter was found to be methylated within the 1919 and 1987 region (-325 to -257), relative to the transcription start site through methylation-specific PCR in the HeLa, SiHa and Caski cervical cancer cell lines. However, a reverse transcription PCR analysis of the TIMP2 gene confirmed a normal expression in the HeLa and SiHa cell lines with a high expression in the Caski cell line, indicating that expression of the TIMP2 gene is independent of methylation of CpG sites located within the -325 to -257 region of the TIMP2 promoter, relative to the transcription start site.

Entities:  

Year:  2012        PMID: 22783395      PMCID: PMC3389666          DOI: 10.3892/ol.2012.608

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  13 in total

1.  A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer.

Authors:  Hiromu Suzuki; Edward Gabrielson; Wei Chen; Ramaswamy Anbazhagan; Manon van Engeland; Matty P Weijenberg; James G Herman; Stephen B Baylin
Journal:  Nat Genet       Date:  2002-05-06       Impact factor: 38.330

2.  Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells.

Authors:  I-Wen Teng; Pei-Chi Hou; Kuan-Der Lee; Pei-Yi Chu; Kun-Tu Yeh; Victor X Jin; Min-Jen Tseng; Shaw-Jenq Tsai; Yu-Sun Chang; Chi-Sheng Wu; H Sunny Sun; Kuen-Daw Tsai; Long-Bin Jeng; Kenneth P Nephew; Tim H-M Huang; Shu-Huei Hsiao; Yu-Wei Leu
Journal:  Cancer Res       Date:  2011-04-25       Impact factor: 12.701

3.  Human papillomavirus vaccine initiation among adolescent girls in high-risk communities.

Authors:  Sarah L Guerry; Christine J De Rosa; Lauri E Markowitz; Susan Walker; Nicole Liddon; Peter R Kerndt; Sami L Gottlieb
Journal:  Vaccine       Date:  2011-02-01       Impact factor: 3.641

4.  Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases.

Authors:  Y A DeClerck; N Perez; H Shimada; T C Boone; K E Langley; S M Taylor
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

5.  A gene hypermethylation profile of human cancer.

Authors:  M Esteller; P G Corn; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

6.  MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.

Authors:  B Davidson; I Goldberg; J Kopolovic; L Lerner-Geva; W H Gotlieb; G Ben-Baruch; R Reich
Journal:  Gynecol Oncol       Date:  1999-06       Impact factor: 5.482

7.  IGSF4 promoter methylation and expression silencing in human cervical cancer.

Authors:  Jianduan Li; Zhengyan Zhang; Miri Bidder; Margo C Funk; Loan Nguyen; Paul J Goodfellow; Janet S Rader
Journal:  Gynecol Oncol       Date:  2005-01       Impact factor: 5.482

8.  Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence.

Authors:  Laura Beatriz da Silva Cardeal; Carla Abdo Brohem; Tatiana Caroline Silveira Corrêa; Sheila Maria Brochado Winnischofer; Fabio Nakano; Enrique Boccardo; Luisa Lina Villa; Mari Cleide Sogayar; Silvya Stuchi Maria-Engler
Journal:  Biochem Cell Biol       Date:  2006-10       Impact factor: 3.626

9.  Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma.

Authors:  G J Nuovo; P B MacConnell; A Simsir; F Valea; D L French
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

10.  Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo.

Authors:  S Mohanam; S W Wang; A Rayford; M Yamamoto; R Sawaya; M Nakajima; L A Liotta; G L Nicolson; W G Stetler-Stevenson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150

View more
  4 in total

1.  Promoter methylation-independent reactivation of PAX1 by curcumin and resveratrol is mediated by UHRF1.

Authors:  Gaurav Parashar; Neena Capalash
Journal:  Clin Exp Med       Date:  2015-06-17       Impact factor: 3.984

2.  Differential Expression of ADAM23, CDKN2A (P16), MMP14 and VIM Associated with Giant Cell Tumor of Bone.

Authors:  André Luis Giacometti Conceição; Erica Babeto; Natalia Maria Candido; Fernanda Craveiro Franco; Débora Aparecida Pires de Campos Zuccari; Jane Lopes Bonilha; José Antônio Cordeiro; Marilia Freitas Calmon; Paula Rahal
Journal:  J Cancer       Date:  2015-05-23       Impact factor: 4.207

3.  – (-) Menthol Induces Reversal of Promoter Hypermethylation and Associated Up-Regulation of the FANCF Gene in the SiHa Cell Line

Authors:  Gaurav Parashar; Nidarshana Chaturvedi Parashar; Neena Capalash
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

Review 4.  Gene-Specific Targeting of DNA Methylation in the Mammalian Genome.

Authors:  Arthur Urbano; Jim Smith; Robert J Weeks; Aniruddha Chatterjee
Journal:  Cancers (Basel)       Date:  2019-10-09       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.